Document is current
Any future updates will be listed below
-
Authors
Castro-Espin, Carlota https://orcid.org/0000-0001-9050-7590
Cairat, Manon
Navionis, Anne-Sophie
Dahm, Christina C. https://orcid.org/0000-0003-0481-2893
Antoniussen, Christian S.
Tjønneland, Anne
Mellemkjær, Lene
Mancini, Francesca Romana
Hajji-Louati, Mariem
Severi, Gianluca
Le Cornet, Charlotte
Kaaks, Rudolf https://orcid.org/0000-0003-3751-3929
Schulze, Matthias B.
Masala, Giovanna
Agnoli, Claudia
Sacerdote, Carlotta
Crous-Bou, Marta
Sánchez, Maria-Jose
Amiano, Pilar
Chirlaque, María-Dolores
Guevara, Marcela
Smith-Byrne, Karl https://orcid.org/0000-0002-1932-7463
Heath, Alicia K. https://orcid.org/0000-0001-6517-1300
Christakoudi, Sofia
Gunter, Marc J.
Rinaldi, Sabina
Agudo, Antonio
Dossus, Laure
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (FI19/00197)
Fundación Científica Asociación Española Contra el Cáncer (PRYES211366AGUD)
- License Information
-
More Information
Article History
Received: 5 March 2024
Revised: 9 September 2024
Accepted: 13 September 2024
First Online: 28 September 2024
Competing interests
: The authors declare no competing interests.
: Informed consent was given by all study participants, and ethical approval for the entire EPIC cohort was obtained from the Institutional Review Board of the International Agency for Research on Cancer in Lyon (France) under protocol numbers SC/24/4 and SC/24/6, as well as from local ethics committees in the participating countries. This study is listed at clinicaltrials.gov as NCT03285230.
